Tarceva (Physicians Total Care, Inc.)


Welcome to the PulseAid listing for the Tarceva drug offered from Physicians Total Care, Inc.. This Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Physicians Total Care, Inc.
NON-PROPRIETARY NAME: erlotinib hydrochloride
SUBSTANCE NAME: ERLOTINIB HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2005-07-01
END MARKETING DATE: 0000-00-00


Tarceva HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTarceva from Physicians Total Care, Inc.
LABELER NAME: Physicians Total Care, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 25(mg/1)
START MARKETING DATE: 2005-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54868-5290_fb809355-146a-4baf-a029-a80b7faee7bb
PRODUCT NDC: 54868-5290
APPLICATION NUMBER: NDA021743

Other ERLOTINIB HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalTARCEVA
Genentech, Inc.TARCEVA
Physicians Total Care, Inc.Tarceva